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Isoenzymes of phosphoglycerate kinase in Trypanosoma bru-
cei are differentially expressed in its two main life stages. This
study addresses how the organism manages to make sufficient
amounts of the isoenzyme with the correct localization, which
processes (transcription, splicing, and RNA degradation) con-
trol the levels of mRNAs, and how the organism regulates the
switch in isoform expression. For this, we combined new quan-
titativemeasurements of phosphoglycerate kinasemRNAabun-
dance, RNA precursor stability, trans splicing, and ribosome
loading with published data and made a kinetic computer
model. For the analysis of regulation we extended regulation
analysis. Although phosphoglycerate kinasemRNAs are present
at surprisingly low concentrations (e.g. 12molecules per cell), its
protein is highly abundant. Substantial control of mRNA and
protein levels was exerted by both mRNA synthesis and degra-
dation, whereas splicing and precursor degradation had little
control onmRNA and protein concentrations. Yet regulation of
mRNA levels does not occur by transcription, but by adjusting
mRNA degradation. The contribution of splicing to regulation
is negligible, as for all cases where splicing is faster than RNA
precursor degradation.
The flux through ametabolic pathway depends on the kinetic
characteristics and concentrations of the constituent enzymes,
on the levels of co-enzymes, and on their compartmentation.
The concentrations of the enzymes in turn depend on the rates
of transcription, processing, nuclear export, translation, degra-
dation of the mRNA, and protein processing and degradation.
Because each of these levels can in principle be regulated, the
challenge is how to analyze the behavior of such a complex
system in terms of the underlying processes.
Metabolic control analysis (MCA)4 and extensions that
include gene expression is a powerful approach for the analysis
of complex biochemical networks (1–4). In MCA, the control
exerted by an enzyme on a concentration of any substanceX (5)
is quantified by its concentration control coefficient, which is
defined as the percentage increase of the steady-state concen-
tration of X that results from a 1% activation of the enzyme of
interest. The sumof the concentration control coefficients of all
the enzymes in the network is 0. This reflects that (i) activation
of some enzymes increases the concentration of X, whereas
activation of other enzymes should reduce the concentration of
X (these enzymes have negative concentration control coeffi-
cients), and (ii) the positive controls together are equal to the
negative controls. The principles of MCA do not only apply to
metabolic pathways; they can also be used and extended to dis-
sect the control distribution in regulatory pathways beyond
steady state (for example see Refs.6 and 7) or gene expression
cascades (for example see e.g. Ref. 8). Earlier MCA, as also
applied to trypanosomes, has looked more at the control of
fluxes, showing that usually flux control coefficients are smaller
than 1, because several enzymes partially control the flux (for
example see Refs. 9–11). In this study we shall focus on the
control of mRNA and protein concentrations.
Questions about control (used strictly in the MCA sense)
may be considered as what if questions. If the cell were to
increase the concentration of a controlling enzyme or if a sci-
entist were to add an inhibitor of this enzyme, the control coef-
ficient indicates the extent to which a flux or concentration
should change.Control coefficientsmay be viewed as thepoten-
tial to regulate. To understand how a flux is actually regulated
when the cell copes with a certain challenge, a complementary
concept is required. To this aim regulation analysis has been
developed. In its original form (12, 13), it dissects towhat extent
a metabolic flux is regulated by metabolism and to what extent
by gene expression. An enzyme rate v is usually the mathemat-
ical product of the enzyme capacityVmax, which depends on the
enzyme concentration e, and a metabolic function, which
depends onmetabolite concentrationsM and affinity constants
K as shown in Equation 1,
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  Vmaxe fM,K (Eq. 1)
Taking the logarithm of both sides of this equation and com-
paring two different conditions, one obtains Equation 2,
log  logVmaxe logfM,K (Eq. 2)
Dividing by logv yields Equation 3,
1 
logVmaxe
log

logfM,K
log
 hierarchical metabolic
(Eq. 3)
in which hierarchical and metabolic are the hierarchical (i.e. gene
expression) and metabolic regulation coefficients. The hierar-
chy of gene expression can be further dissected to analyze reg-
ulation at the levels of transcription, precursor splicing and
degradation, mRNA degradation, translation, and protein deg-
radation (14).
In this study, we use a “bottom-up” systems biology approach
(15) and the principles of MCA and regulation analysis to elu-
cidate the control and regulation of the phosphoglycerate
kinase (PGK) gene expression cascade in Trypanosoma brucei,
a flagellated unicellular parasite. T. bruceimultiplies as “blood-
stream form” in the blood and tissue fluids of mammals and as
“procyclic form” in themidgut of tsetse flies. Both forms can be
maintained indefinitely in culture. In bloodstream trypano-
somes, glycolysis is simple but has unique features: pyruvate is
excreted as the dominant end product; nine enzymes of the
glycolytic pathway and glycerol metabolism are compartmen-
talized in a microbody (the glycosome); and gluconeogenesis
is absent. In the procyclic form, energy metabolism is more
diverse, with major contributions from the mitochondrion
(16).
T. brucei bloodstream form glycolysis is an attractive model
to initiate quantitative studies of control and regulation,
because both the glycolytic pathway and themechanisms avail-
able for regulating gene expression are simpler than in other
eukaryotes, including yeasts. The kinetic characteristics and
activities of all of the (known) enzymes, and the concentrations
of all the (known) metabolites, have been determined.We have
previously used this information to develop a robust model of
bloodstream trypanosome glycolysis, which not only explained
known pathway characteristics but also predicted conse-
quences of perturbations of the system that have since been
verified experimentally (10, 11, 17–21).
Similarly, the T. brucei gene expression cascade is simpler
than that of other organisms, because transcription by RNA
polymerase II appears to be constant for all genes during expo-
nential growth. The protein-encoding genes are organized in
polycistronic transcription units that may contain 100 or more
open reading frames; promoters for these have previously
proven elusive (22–24). Mature mRNAs are formed through
co-transcriptional 5-trans splicing of a capped 39-nucleotide
spliced leader (SL), and coupled 3-polyadenylation (25). Thus,
in contrast to nearly all other organisms from prokaryotes to
man, trypanosome gene organization precludes the differential
regulation of expression of individual protein-coding genes at
the level of transcription initiation. Alternative regulation
points are RNA processing, export from the nucleus, transla-
tion, and degradation. So far, there is strong evidence only for
regulation of mRNA degradation and translation (26), but the
strength of this regulation is unclear.
There are three PGK genes in the trypanosome genome, i.e.
PGKA, PGKB, and PGKC. They are adjacent to each other in a
single transcriptional unit (27). Although the three PGK genes
are co-transcribed, they have different expression patterns (27).
The PGKA protein and mRNA are present at low levels in the
glycosomes of all life stages of the parasite (28, 29). PGKB and
PGKC have distinct expression patterns as follows. The cytoso-
lic PGKB protein and its mRNA are predominantly expressed
in the procyclic form, and the glycosomally localized PGKC
isoenzyme (and the PGKC mRNA) is the predominant isoen-
zyme in the bloodstream form (27, 30). The total cellular PGK
activity does not differ much between bloodstream- and insect
form trypanosomes. However, correct localization of PGK
activity, and hence regulation of PGKB and PGKC expression,
are vital, because cytosolic PGK activity causes growth arrest of
bloodstream form trypanosomes (31). Qualitatively, the
expression patterns of the isoenzymes can be explained by the
different stabilities of their maturemRNAs, depending on their
3-untranslated regions (UTRs) (32–36). There might be addi-
tional regulation at the levels of splicing (37, 38), translation
(39), and variations in protein stability, but the quantitative
importance of these processes is unknown, and there has not
been a methodology even to establish this.
In this studywe developed thismethodology and applied it to
the PGK isoenzyme expression in T. brucei. We measured
accessible properties of the expression of the PGKB and PGKC
genes and analyzed the distribution of control and regulation of
the expression of the PGK locus. We built a quantitative com-
puter model of the bloodstream form to help us do this. We
found that in bloodstream form trypanosomes the control of
the PGK mRNA concentrations is distributed between tran-
scription, splicing, and mRNA degradation, whereas T. brucei
only uses mRNA degradation to regulate the PGKmRNA con-
centrations when it differentiates from the bloodstream to the
insect form.
EXPERIMENTAL PROCEDURES
Cell Culture—Bloodstream form cell line BF449 (40) was cul-
tivated in HMI-9 medium supplemented with 10% fetal calf
serum (Invitrogen) and 0.2 g/ml phleomycin (Cayla) in an
air-saturated incubator at 37 °C and 5% CO2. Procyclic PF449
was cultivated in SDM-79 medium with 10% fetal calf serum
(Invitrogen) and 0.2 g/ml phleomycin in closed culture flasks
at 30 °C (41).
RNA Isolation andQuantification ofMature TUBAand PGK
mRNA—Total RNA was isolated in the exponential phase of
growth (bloodstream forms maximally 2  106 cells/ml and
procyclic cells maximally 5  106 cells/ml), using peqGOLD-
Trifast (peqLab) or TRIzol (Invitrogen) according to the man-
ufacturer’s instructions. Tracer RNAs were made from a
983-bp fragment of the -tubulin (TUBA) gene (positions
3–986) cloned into pGEMTeasy (pHD1792), and gPGK44-1,
which contains the PGKC coding region plus 33 bp of its
5-UTR (42). Northern blot analysis confirmed the presence of
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a single length product. The plasmid DNAs were linearized
with SpeI orXhoI, respectively, and transcribed byT7 polymer-
ase or, alternatively, linearized with BamHI and transcribed
with T3 polymerase. To measure the yield of mRNA, the tubu-
lin tracer was added to either theTrifast solution or the purified
RNA; the relative intensities of the tubulin signals were meas-
ured afterNorthern blotting. The average yield of this RNAwas
55%.
Total RNA was denatured in formamide at 95 °C and sepa-
rated by electrophoresis on formaldehyde/formamide-agarose
gels. The RNA was blotted onto neutral nylon membranes
(Nytran), stained with methylene blue to check for even trans-
fer, and then hybridized with the PGK or TUBA probe tracer
fragments that had been labeled by random priming or PCR
with 32P-labeled nucleotides. SRP RNA (43) was used as a load-
ing control. Signals were detected and measured by phospho-
rimaging. To quantify the absolute amounts of PGK or TUBA
mRNA in trypanosomes, various known amounts of the pure
tracer mRNAs (see above) were added to the lysate before
mRNA isolation. To calculate the amounts back into mole-
cule numbers, we used mature and precursor RNA lengths
and assumed amean nucleotide monophosphate mass of 339
g/mol.
Ribonuclease Protection Assay—To quantify kinetics of pre-
cursor splicing and degradation, exponentially growing cell cul-
tures with a density of 1–2 106 cells/ml were incubated either
with Sinefungin (1 or 2 g/ml) for 30 min with subsequent
incubation with actinomycin D (10 g/ml) for 0–25 min or
with actinomycin D alone. Cells were pelleted by centrifuga-
tion, after which supernatant was removed and pellet was taken
up in TRIzol (Invitrogen) for total RNA isolation. The RNase
protection probe formeasurement of PGKB/Cprocessingwas a
BamHI-SpeI fragment subcloned from pHD1417 (34) into
pBluescript KS (pHD1402). The fragment contains the regions
from the PGKB stop codon to the PGKC start codon, without
the regulatory U-rich element. As a control for product identi-
fication, a similar construct with the U-rich element present
was also used (pHD1402). RNase protection assays with the
full-length probe yielded multiple products, presumably
because of “breathing” of A-U rich hybrids. The full-length
probe therefore could not be used for quantification of precur-
sor. The plasmids were cut with SalI, and probes were tran-
scribed by T7 polymerase (MAXIscript, Ambion) in the pres-
ence of ATP, CTP, GTP, and [-32P]UTP. RNase protection
analysis was performed using RNase protection analysis III kit
(Ambion). Each RNase protection reaction included 10 g of
trypanosome RNA and 8  104 cpm of probe (Cerenkov
counts). If twice as much probe was used, the signals were sim-
ilar indicating that probe was in excess. A 32P-labeled 10-bp
Invitrogen DNA ladder served as a size marker. Products were
run on 5% denaturing polyacrylamide/urea gels for 4–6 h,
removed from the glass plates, put onto a piece of Whatman
paper, and vacuum-dried overnight. Controls contained only
1 104 cpm of probe. Signals were detected and measured by
phosphorimaging. Degradation curves were analyzed using the
Kaleidagraph program. To check the precursor status of band
“a,” we used RNA prepared from trypanosome with inducible
RNA interference against SMD1 (44) or cleavage and polyad-
enylation factor CPSF30 (45). The identities of bands were con-
firmed by using shorter probes specific for the 5 end of the
PGKC mRNA and the spacer region, and by assessing stage
specificity (not shown).
Polysome Analysis—Polysomes were isolated as described in
Ref. 46. RNA was purified as described above, and the distribu-
tion of different RNAs was analyzed by Northern blotting.
Purification of TbPGKC—Escherichia coli BL21(DE3)pLysS
cells (a kind gift of Prof. P. Michels) containing the plasmid
TbPGKC (47) were grown, treated with isopropyl 1-thio--D-
galactopyranoside to induce TbPGKC expression, and har-
vested according to the published protocol. In short, cells were
harvested and lysed, and nucleic acids were digested, and
lysates were treated with protamine sulfate. The supernatant
was then concentrated with a YM-10 filter and applied to a
Resource S column (Amersham Biosciences) connected to an
Akta Explorer fast protein liquid chromatography (Amersham
Biosciences). Proteins were eluted with a linear gradient of
50–400 mM NaCl in the loading buffer. Peak fractions from
columnpurificationwere tested enzymatically for PGKactivity,
and the samples with activity were evaluated on a silver-stained
SDS-polyacrylamide gel. All fractions that had PGK activity
were 90% pure (as judged from Coomassie Blue and Silver
staining of SDS-polyacrylamide gels; data not shown). This was
pure enough to enable us to use the fractions as standards on
Western blots. Protein concentration was determined with a
BCA (Pierce) assay using bovine serum albumin (Pierce) as a
standard.
Quantitative Immunoblotting—For each sample 3 106 cells
were harvested by centrifugation, washed in phosphate-buff-
ered saline, and finally resuspended in 15l of phosphate-buff-
ered saline and 15l of Laemmli buffer. Samples were stored at
80 °C before analysis.
Protein samples and purified TbPGKC were boiled for 5–10
min at 95 °C and run on an SDS-polyacrylamide gel (12%). As
gel and transfer inhomogeneities are themajor source of corre-
lated errors in immunoblotting (48), we randomized samples
on every blot. Proteins were transferred to a methanol-acti-
vated polyvinylidene difluoride membrane (Bio-Rad) by blot-
ting overnight at 4 °C and 20V. Membranes were subsequently
placed for 1 h in block buffer, containing 5% (w/v) skim milk
powder in TBST (Tris-buffered saline with 0.05% (v/v) Tween
80)). After five wash steps in TBST the blot was submerged in
block buffer with PGKC antibody Do425 (kind gift from Prof.
Paul Michels; raised against recombinant PGKC (47))
(1:10,000) for 1 h. After washing, blots were put in block buffer
with horseradish peroxidase-linked anti-rabbit IgG (DAKO
A/S,Denmark) (1:2000) for 1 h andwashed inTBST, andhorse-
radish peroxidase activity was measured after a 2-min incuba-
tion with LumilightPLUS Western blotting substrate (Roche
Applied Science). Quantitation was done with Quantity One
software (Bio-Rad) by total surface scan, which was corrected
for differences in spot width. With different dilutions of cell
lysate and standard it was checked if the appearing bands were
in the linear range of the blot. Background was subtracted from
the PGKC bands, and for each separate blot, the PGKC band
was comparedwith the standards so as to obtain themass of the
PGKC in the cell lysate lanes. From the number of cells in the
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lysate (determined by cell count), the molecular weight of the
protein (47 kDa), and Avogadro’s number, we calculated the
number of PGKC molecules per cell.
Calculations and Graphs—Steady-state calculations were
done in Excel (Microsoft). Data were plotted with Sigmaplot or
Kaleidograph. The transcription model for PGK was con-
structed in Jarnac 2.0 (49, 50).
Jarnac calculates the control coefficient of any process i on
any steady-state concentration X numerically by varying a
parameter pi that linearly affects a rate vi, by a small percentage,
from Equation 4,
Ci
x   X/Xpi/pi
steady state
vi/vipi/pi
instantaneous
(Eq. 4)
The parameters that were varied were: vtranscription, , kdegrP,
ksplicing, kdegrB, kdegrC, and ktransl (see model description or
Table 1 for the meaning of these parameters).
RESULTS
To construct a quantitative model of the dynamics of PGK
expression, we started by collecting quantitative data about the
concentrations and turnover rates of
themost importantmolecular players.
Amount of RNA in Trypanosomes—
The total amount of RNA was
measured in lysates from cultured
trypanosomes to which different
amounts of tracer RNA were added
prior or subsequent to the isolation
procedure. More than 10 measure-
ments of each form showed that
bloodstream form trypanosomes
contain 0.5  0.1 pg (mean  S.E.)
of total RNA per cell, whereas pro-
cyclic trypanosomes had 2.2-fold
more RNA per cell. A previous esti-
mate reported 0.8 pg per procyclic
trypanosome (51). Depending on
the growth conditions, Saccharo-
myces cerevisiae has 0.5–1.6 pg of
RNA/cell, of which 85% is rRNA
and 10% is tRNA and other small
RNAs (52).
If 85% of the trypanosome RNA is
ribosomal, 0.5 pg of RNA should
correspond to 1.2 105 ribosomes.
Results from purification with oli-
go(dT) or poly(U) affinity resins or
from Northern blots suggested that
trypanosome mRNA represents 5%
of the total RNA or 0.025 pg/cell
(53–55). Assuming an average
mRNA size of 2.2 kb (see Supple-
mentalMaterial), there are	20,000
mRNA molecules per bloodstream
trypanosome and 6 ribosomes per
mRNA molecule.
Amounts and Turnover of PGK and TUBA mRNAs—North-
ern blotting with PGK standards (Fig. 1A) showed that blood-
stream form trypanosomes contained 12.1  7.7 (S.D., n 
 5)
molecules of PGKCmRNA (this study) and 15 times less PGKB
mRNA per cell (33). In procyclic trypanosomes, there were
18 2 (S.D., n
 5) PGKB mRNAs per cell, and PGKCmRNA
was not detectable, as expected from previous reports (Gibson
et al. (27); Colasante et al. (33)).With quantitative PCR we do
detect PGKC mRNA in procyclics, but at 12 times less abun-
dant than in bloodstream forms when compared with the
housekeeping gene hypoxanthine-guanine phosphoribosyl-
transferase. Hypoxanthine-guanine phosphoribosyltransferase
mRNA levels are similar in bloodstream and insect stages of T.
brucei (56). For comparison we also measured the number of
-tubulin (TUBA) transcripts, usingTUBA standards (Fig. 1A).
Bloodstream form trypanosomes contained 72 12 molecules
of TUBAmRNA per cell.
Half-lives of mRNAs were measured previously. To measure
mRNAdecay kinetics in trypanosomes, it is necessary to inhibit
mRNA processing and transcription. Using actinomycin D and
Sinefungin, the half-life of PGKC mRNA in bloodstream
trypanosomes was 45 min (33). In procyclic trypanosomes, a
FIGURE 1. A, quantitation of PGKC and PGKB mRNA levels. Northern blot analysis of PGKB (lower band) and PGKC
(upper band) transcripts in 4 107 bloodstream (Bs) or procyclic (Pc) cells. In vitro transcribed PGKmRNA (0.25 ng)
was added to the BS lysate prior to RNA preparation. SRPwas used as a loading control. B, quantitation of PGKC
protein levels. Recombinant TbPGKCandbloodstream form lysateswere separatedbySDS-PAGEandblottedonto
a polyvinylidene difluoride membrane. The band around 50 kDa is shown. The numbers below indicate protein
amount (for standards) or thenumberof cells.C,associationofPGKmRNAwithpolysomes inbloodstreamtrypano-
somes. Sucrose gradient fractions from bloodstream form (Bs) (left) or procyclic (Pc) (right) trypanosomes were
analyzed by spectrophotometry (A280), then RNAwas extracted and PGKmRNAdetected byNorthern blotting. On
the upper panel showing the A280 trace, with downward fractionmarkers, the approximate ribosome numbers are
indicated. The fraction numbers are indicatedbelow the trace. RNA corresponding to the fractions is shownbelow.
The ethidiumbromide stain shows the three ribosomal RNAs, and theNorthernblotwas probedwith aPGKprobe.
Pure bloodstream (Bs) and procyclic (Pc) total RNAs are included as controls.
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reporter (chloramphenicol acetyltransferase) mRNA bearing a
PGKC 3-untranslated region (UTR), produced by T7 RNA po-
lymerase, had a half-life of about 5min (33); the low abundance
of the endogenous PGKCmRNA in this T. brucei form renders
direct measurement of its half-life problematic. For PGKB,
measurements have beenmade using actinomycin D inhibition
alone, which can result in overestimates of stability (33). A
chloramphenicol acetyltransferase reporter with a PGKB
3-UTR (produced by T7 polymerase) had an average half-life
of about 7.5 min in bloodstream form trypanosomes (34), and
thePGKBmRNAshowednegligible decay in procyclic trypano-
somes over 90 min; here we assumed a half-life of 120 min and
when using this estimate we discuss its implications for our
analysis of regulation (see below).
Steady-state PGK Protein Levels and Stability—We next
measured the PGK protein level in bloodstream form trypano-
somes. As a standard we used TbPGKC (47) (Fig. 1B). Compar-
ing the PGKC amount in bloodstream form lysates to known
amounts of standard on three separate Western blots in five
independent samples and using amolecular mass of 47 kDa, we
found 1  106  0.5 molecules per cell (n 
 3; S.E., including
errors between lanes of standard). PGKB could only be seen in
bloodstream forms after grossly overloading the gel.
To check the stability of PGKC, we pulse-labeled blood-
stream form trypanosomes for 30 min with [35S]methionine
and then diluted them into normal medium. PGK was immu-
noprecipitated; the immunoprecipitates were separated by gel
electrophoresis and the proteins detected by autoradiography.
As was seen previously for aldolase in procyclic forms (57), no
degradation of PGKC was detected over the 8-h chase period
(not shown).
Ribosome Density on PGK mRNA—To find out how many
ribosomes transcribed PGK mRNAs simultaneously, we ana-
lyzed their distribution after sucrose gradient centrifugation.
The upper panels of Fig. 1C show the overall protein levels as
judged by the absorbance at 280 nm, and the lower panels show
the ethidium bromide-stained ribosomal RNA and hybridiza-
tion of a Northern blot with a PGK probe. In both procyclic and
bloodstream trypanosomes, the PGK hybridization was con-
centrated at the bottomof the gradient.We extrapolated (using
a logarithmic function) from the portion of the gradient in
which individual ribosomes were visible and concluded that
there were 11–14 ribosomes per PGKC mRNA molecule in
bloodstream forms. Estimates for PGKB in procyclics are less
accurate, but the results are consistent with a comparable ribo-
some density. PGKC mRNA was undetectable in procyclic
forms. In bloodstream forms, PGKB mRNA appeared to be
polysomal, but the interpretation was complicated by artifacts
because of co-migration of the rRNAat the same position in the
blot.
The Kinetics of Splicing and Precursor Degradation—To esti-
mate the rate at which the PGK precursor RNA is trans spliced
in bloodstream form trypanosomes, we measured the rate at
which the PGK polycistronic precursor disappeared under two
conditions. In one condition we inhibited transcription. In the
second condition we inhibited both transcription and splicing.
An RNase protection assay with an antisense probe spanning
the region between the PGKC start codon and the PGKB stop
codon, but excluding the U-rich regulatory region (Fig. 2A),
resulted in bands indicated as a, b, and c in Fig. 2B. The cluster
of prominent bands around 80 nucleotides corresponded to the
5-untranslated region of the PGKC mRNA and was undetect-
able if procyclic RNAwas used (not shown), consistent with the
low abundance of PGKC mRNA in procyclics (Fig. 2, A and B,
labeled as c). Just above these bands was a faint band migrating
around 85 nucleotides, which was the only species observed if
procyclicmRNAwas used. This corresponded to the 3-UTR of
the mature PGKB mRNA (without the U-rich element) (Fig. 2,
A and B, labeled as b). Above these bands was a product that
spanned from the PGKC initiation codon to the end of the
U-rich element, which is approximately the position of the
PGKB polyadenylation site (Fig. 2, A and B, labeled as a). We
took this band to correspond to the PGKB-PGKC precursor. It
was more prominent in trypanosomes in which splicing was
inhibited by addition of Sinefungin (Fig. 2B, lanes 1 and 2). In
our calculations we assumed that it all represents precursor
RNA, although some contribution from aberrantly processed
mRNAs cannot be ruled out.
Actinomycin D inhibits all transcription of DNA, including
that intomRNAs and spliced leader RNA (58). After addition of
actinomycin D, the precursor band disappeared with a half-life
of 1.4 min (ksplicingdegradation of 0.50 min1; Fig. 2C and Table
1); greater precision was precluded by the mechanics of the
assay, which requires diffusion of actinomycin D into the cells
and a centrifugation step. To correct for degradation of precur-
sor RNA, the cells were pretreatedwith Sinefungin, an inhibitor
of splicing in trypanosomes (59, 60). When actinomycin D was
added to these cells, the precursor decayedwith a half-life of 8.2
min (kprecursor degradation of 0.085 min1; Fig. 2, B and C, and
Table 1). Assuming that the Sinefungin incubation had not
affected the precursor degradation rate constant, we estimated
ksplicing at 0.41 min1. This result indicated that in the absence
of Sinefungin,	80%of precursor disappearancewas because of
splicing. Preliminary measurements of PGKC splicing by real
time PCR have been consistent with these RNase protection
assays, but attempts tomeasurePGKC polyadenylation kinetics
have been frustrated by the appearance of what seemed to be
stable RNA species spanning the downstream intergenic
region.5
Quantitative Computer Model of PGK Expression—Based on
the data collected above and some additional information from
the literature, a kinetic model of PGK expression in blood-
stream form trypanosomeswas constructed. Transcription rate
was taken to be constant. Precursor degradation, splicing, deg-
radation of the mature mRNAs, translation, and protein degra-
dation were all described by linear kinetics (Fig. 3). Such linear
kinetics should be obtained if the substrate or activator concen-
tration is below the effectiveMichaelis-Menten or binding con-
stant. This occurs when substrate or activator is a minority
among all substrates or factors competing for the same site on
the enzyme complex catalyzing the process considered. This is
the situation that should be expected in this case, as the PGK
RNAs and proteins are just one of many substrates for enzymes
5 M. Stewart, unpublished results.
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catalyzing splicing, degradation, and synthesis. In the expres-
sions used, the concentration of the enzyme complex is implicit
in the rate constants, with the exception of the equation for the
rate of protein synthesis where the number of ribosomes that
are actually translating themRNA is explicit. The dilution of all
compounds because of population growth was taken into
account based on the specific growth rate  of the cultures.
Polyadenylation was not modeled as a separate process but
implicitly included in the splicing equation. This yielded the
following set of differential Equations 5–9,
dprecursor
dt
 vtranscription	 ksplicing kdegrP precursor
(Eq. 5)
dPGKBmRNA
dt
 ksplicing precursor	  kdegrB
 PGKBmRNA (Eq. 6)
dPGKCmRNA
dt
 ksplicing precursor	  kdegrC
 PGKCmRNA (Eq. 7)
dPGKB protein
dt
 ktransl nribosome PGKBmRNA
	   kdegrPGKB PGKB protein (Eq. 8)
dPGKC protein
dt
 ktransl nribosome PGKCmRNA
	   kdegrPGKC PGKC protein (Eq. 9)
The parameters used are described in Table 1, as are the values
we used for them. The steady state of the systemwas calculated
by setting all time derivatives equal to zero. The calculated
steady-state magnitudes of the variables are given in the col-
umn marked Model A of Table 2. The steady state should be
obtained experimentally when the trypanosomes have been in
constant external conditions for a time much longer than the
slowest relaxation time in the system. Here this should be a
multiple of the inverse of the specific growth rate. The rate of
transcription and the rate constant of translation were fitted to
match the measured PGKCmRNA and PGKC protein, respec-
tively, with that of the model. With the resulting parameter set
also the model’s PGKB mRNA concentration, which was not
fitted, was close to the value determined experimentally. The
calculated concentration of PGKB protein of slightly under 0.2
million per cell is probably an overestimate. We could not
detect PGKB protein on Western blot without grossly over-
FIGURE2.RNaseprotectionassays formeasurementofPGKRNAprocess-
ing.A, panel 1, beforeprocessing, theprimary transcript extendsbetween the
PGKB and PGKC open reading frames. The precursor and PGKB 3-UTR contain
a U-rich instability element (URE, shaded), and the precursor also has a U-rich
polypyrimidine tract that signals trans splicing (UU). The 135–140-nt spliced
leader precursor RNA (black) carries the 39-nt spliced leader (hexagon). The
330-nt RNase protection probe includes all of the regions between the open
reading frames, apart from the instability element, and also extends at both
ends through polylinker sequence. Panel 2, after RNase digestion, any probe
thatwas hybridizedwith theprecursorwould be cut into 2pieces; fragment b
corresponds to the 3-UTR of PGKB, whereas fragment a is diagnostic of the
unspliced PGKC precursor. During splicing, a branch is formed upstream of
the polypyrimidine tract (3). RNase protection product b is diagnostic of both
precursor RNA and mature PGKB. Fragment c corresponds to trans spliced
PGKC RNA. B, typical RNase protection result. Trypanosomes were incubated
either with Sinefungin (1 or 2 g/ml) plus actinomycin D (ActD, 10 g/ml),
indicated with degradation in lanes 2–6, or with actinomycin D alone, indi-
cated with splicing and degradation in lanes 7–9. The time of incubation in
minutes is shown above the lanes. M, marker; R, no trypanosome RNA
added; P,probe alone.C,quantitationof “band a” (diagnostic for precursor) in
four independent experiments doneondifferent batches of cells. Each exper-
iment is represented by a different symbol, with solid symbols/solid line for
precursor degradation (actinomycin D  Sinefungin), and open symbols/
dashed line for splicing plus degradation (actinomycin D alone). The curves
were fit to an exponential decay function using Kaleidograph. Half-lives
measured from the curves are shown.
Control and Regulation of Gene Expression
2500 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 5•FEBRUARY 1, 2008
 at Vrije Universiteit, Medical Library, on December 21, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
loading the gel, and our detection limit was about 1 105 mol-
ecules per cell. This suggests that there is some negative trans-
lation regulation. This wouldmake sense, because active PGKB
protein in the cytosol would be detrimental to bloodstream
form cells (31).
Based on the measured kinetics of precursor processing and
RNA degradation, the model predicted that the precursor con-
centration would be 25 times lower than that of the mature
PGKC mRNA, whereas a 300-fold lower concentration was
measured (Table 2). According to the model the precursor
RNA concentration is approximated by the transcription rate
divided by the splicing rate constant, given that the precursor
degradation and dilution because of growth are slow compared
with splicing (cf. Equation 5).
Given the technical limitations in our experiments, we con-
sidered the possibility that the actual splicing rate was faster
than we had measured. A particular issue is that fact that acti-
nomycin D may not have penetrated the cells instantaneously.
Increasing ksplicing in the model substantially lowered the con-
centration of the precursor with little effect on thematuremes-
senger levels (Fig. 4). At a ksplicing of 5min1, the precursor level
did correspond to the value determined experimentally.
Decreasing the transcription rate in the model also decreased
the precursor level. However, this also decreased the level of
mature mRNAs to far below what was observed. This led us to
formulate a model B which was identical to model A, except
that the ksplicing had been increased to 5 min1.
Control Analysis—Subsequently both models were used to
calculate what controlled the concentrations of precursor
RNA, PGKB mRNA, and PGKC mRNA in bloodstream forms,
according to the concepts of metabolic control analysis. For
model A this was done at themeasured rate constant of splicing
and for model B at the fitted splicing rate constant that led to
the more realistic precursor concentration. We only show the
results formodelA in themain text, butwe discuss how those of
model B are different (see the Supplemental Material).
Transcription was fully limiting for the concentrations of all
mRNAs, i.e. the corresponding control coefficientswere all 1.00
(Table 3). In addition the steady-state concentrations of the two
FIGURE3.General representationof factorsaffectingametabolicprocess
in trypanosomes. Reactions used in our quantitative model for PGK expres-
sion are shown with rate equations. Parameters for these equations are
described and listed in Table 1. Export of the mRNA from the nucleus is not
included in the diagram. Solid arrows showmass flow; dashed arrows showan
information flow. For brevity,degradation iswritten for degradationplus dilu-
tion because of population growth.
FIGURE 4. Modeled relationship between ksplicing and precursor and
mRNA concentrations.
TABLE 1
Parameters characterizing PGK synthesis in bloodstream form T. brucei
To obtain the rate constants, half-lives reported in this study and elsewhere were recalculated to rate constants by using k
 ln2/t1⁄2, in which t1⁄2 is the half-life in minutes
and k the rate constant in min1.
Parameter Value Unit Description Origin of numbers
vtranscription 0.24 Molecules cell1 min1 Transcription rate Fitted to match measured levels of PGKCmRNA
ksplicing 0.41 min1 Kinetic constant of splicing This papera
kdegrP 0.08 min1 Kinetic constant of precursor degradation This paper
 0.0019 min1 Specific growth rate Measured in cultures used in this study
kdegrB 0.092 min1 Kinetic constant of PGKB mRNA degradation Observations with reporter constructs (34)
kdegrC 0.015 min1 Kinetic constant of PGKC mRNA degradation Half- life of 45 min (33)
ktransl 13.4 Proteins ribosome1 min1 Kinetic constant of translation Fitted to match measured levels of PGKC protein
nribosome 12 Ribosomes transcript1 No. of ribosomes per transcript This paper
kdegrPGKB 0 min1 Kinetic constant of PGKB degradation This paper and as observed for other enzymes (11, 57, 82)
kdegrPGKC 0 min1 Kinetic constant of PGKC degradation This paper and as observed for other genes (11, 57, 82)
a ksplicing
 kprocessing kdegrP; kprocessing was measured by inhibition of transcription by actinomycin D (see also Fig. 2C).
TABLE 2
Steady-state concentration of precursor and PGKmRNA and PGK
protein in bloodstream form T. brucei (experimental data versus
model values)
Model values in italics were the result of a fit to the experimental value and hence
identical to that value.
Measured Model A Model B Units
Precursor 0.03 0.01a 0.5 0.05 Molecules cell1
PGKBmRNA 0.8a 2 2.5 Molecules cell1
PGKCmRNA 12 8 12 14 Molecules cell1
PGKB protein NDb 1.8 105 2.1 105 Molecules cell1
PGKC protein 1 0.5 106 1 106 1.2 106 Molecules cell1
a BloodstreamT. bruceihave about 15 less PGKBmRNAthanPGKCmRNA(33, 36).
bNDmeans not detectable.
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mature PGKmRNAs were controlled by processing of the pre-
cursor, by degradation of the mature and the precursor tran-
scripts, and by cell growth. The control by the splicing process
was positive, but control by all the others was negative, reflect-
ing that activation of the latter three processes should decrease
the mRNA concentrations (Table 3). In fact the control by
mRNA degradation was almost as strong as that by transcrip-
tion, and surprising to us with a much smaller control by the
splicing process. Indeed, most of the negative control was
exerted by degradation of the mature messengers.
The negative control by the growth process is something one
could readily overlook in intuition-based analyses; mathemati-
cal calculations have the advantage that they tend to be com-
prehensive. This negative control is because of the halving of
the number of mature mRNAs per cell at each cell division and
can be particularly strong for the control of stable compounds
in rapidly growing organisms. In our model the PGKC tran-
script concentration was more strongly controlled by the
growth rate of the parasites than was the PGKB transcript con-
centration. By in silico experimentation with the model, we
verified this difference was because the rate constant of PGKB
mRNA degradation was 2 orders of magnitude higher than the
specific growth rate, whereas that of PGKCmRNAdegradation
was closer to the specific growth rate. Somewhat more surpris-
ingly, for both messengers the absolute control of mature tran-
script concentrations by the degradation of the precursor almost
equaled that by the splicing (0.16 and 0.17 respectively),
whereas there is an 8-fold difference between their half-lives.
When the splicing rate constant ksplicing was increased to 5
min1 to match the measured precursor concentration
(model B, see above), the control of precursor processing on
the levels of mature messenger became even lower, i.e.0.02
for control of precursor degradation and0.02 for control of
splicing on PGKB and PGKCmRNA levels. Most control was
again exerted by transcription and mRNA degradation (see
supplemental Table 3B).
In the model the control exerted by transcription, precursor
degradation, precursor splicing, and mature mRNA degrada-
tion on the concentrations of the PGKB and PGKC protein
concentrations equaled that exerted on the corresponding
mRNA concentrations. This was because of themodel assump-
tion that translation and protein synthesis are unregulated and
linearly dependent on the concentrations of mRNA and pro-
tein, respectively. This makes the steady-state protein concen-
trations linearly dependent on the corresponding steady-state
mRNA concentrations (cf. Equations 8 and 9). However, not
only transcription but also translation has strong positive con-
trol (1.00) on the level of PGK proteins. Because the sum of the
concentration control coefficients should be zero again, there
must be a negative contribution to compensate for this. Indeed
the negative control coefficients by the growth rate are higher
for the proteins than for the corresponding mRNAs, and the
difference is precisely 1.00. In theory this extra negative control
of1.00 compared with the control of growth onmRNA levels
could have resided in growth and protein degradation. How-
ever, because PGKC was shown to be stable in bloodstream
forms, growth is the only factor that accounts for the extra
negative control needed on the protein level.
In reality regulation of translation and/or protein degrada-
tion may modify the dependence of the protein concentrations
on the mRNA concentrations, and this should then influence
the control exerted by transcription andRNAprocessing on the
protein concentrations. However, even in the latter case, the rela-
tive contributions of the processes at the RNA level to the control
of protein concentrations should remain unaltered.
Regulation Analysis—To find out at which levels the cell reg-
ulates the mRNA levels when shifting from bloodstream form
to procyclic form, we extended and applied regulation analysis
(see Introduction). At steady state, the concentrations of each
transcript i and of its precursor are constant (cf.Equations 5 and
6), see Equations 10 and 11,
dmRNAi
dt
 ksplicing precursor	  kdegr_i
 mRNAi 0 (Eq. 10)
dprecursor
dt
 vtranscription	 ksplicing kdegrP
 precursor 0 (Eq. 11)
Combination of Equations 10 and 11 yields Equation 12,
mRNAi
vtranscription ksplicing
ksplicing kdegrP  kdegr_i
(Eq. 12)
In logarithmic space we have Equation 13,
logmRNAi logvtranscription log ksplicingksplicing kdegrP
	 log kdegr_i (Eq. 13)
TABLE 3
Concentration control coefficients calculated using Model A, i.e. ksplicing 0.41 min
1, as was measured
Control ona
Control by
SumbTranscription Growth Precursordegradation
Precursor
splicing
Degradation
PGKBmRNA
Degradation
PGKCmRNA Translation
Precursor 1.00 0.00 0.16 0.83 0.00 0.00 0.00 0.00
PGKBmRNA 1.00 0.02 0.16 0.17 0.98 0.00 0.00 0.00
PGKCmRNA 1.00 0.12 0.16 0.17 0.00 0.89 0.00 0.00
PGKBmRNA/PGKCmRNA 0.00 0.09 0.00 0.00 0.98 0.89 0.00 0.00
PGKB protein 1.00 1.02 0.16 0.17 0.98 0.00 1.00 0.00
PGKC protein 1.00 1.12 0.16 0.17 0.00 0.89 1.00 0.00
PGKB protein/PGKC protein 0.00 0.09 0.00 0.00 0.98 0.89 0.00 0.00
a Brackets refer to number of molecules per cell.
b The sum was calculated before rounding off the numbers.
Control and Regulation of Gene Expression
2502 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 5•FEBRUARY 1, 2008
 at Vrije Universiteit, Medical Library, on December 21, 2011
w
w
w
.jbc.org
D
ow
nloaded from
 
If we consider a transition from one state to another, e.g. from
one life stage to the other, we have Equation 14,
logmRNAi logvtranscription
 log ksplicingksplicing kdegrP	 log kdegr_i
(Eq. 14)
Division through log[mRNA] yields Equation 15,
1  transcription precursor processing degradation (Eq. 15)
This can be written as Equation 16,
logmRNAi
logmRNAi

logvtranscription
logmRNAi

log ksplicingksplicing kdegrP
logmRNAi
	
log kdegr_i
logmRNAi
(Eq. 16)
Here the “transcription regulation coefficient of mRNAi,” i.e.
transcription, quantifies the extent to which a specific steady-
state mRNA concentration is regulated by the organism tuning
the transcription of the corresponding gene. It equals
logvtranscription/logv[mRNAi]. precursor processing quantifies
the regulation of the steady-state mRNA concentration by the
organism altering the precursor degradation and the splicing
processes.
precursor processing 
log
ksplicing
ksplicing kdegrP
logmRNAi

log1	 kdegrPksplicing 
logmRNAi
(Eq. 17)
degradation quantifies the regulation by the organism tuning the
degradation of the processes and the mature mRNA or its
growth rate. It equals minus kdegr_i)/log[mRNAi].
It follows from these equations that regulation of mature
mRNAs through changing precursor processing is negligible
as long as trans splicing is fast compared with precursor
degradation and cell growth. Then kdegrP  ksplicing and
precursor processing is very small. In particular, an increase in
precursor processing could have no stronger effect than an
increase in PGKB mRNA by 25% (which is also reflected
in Fig. 4), whereas an 	23-fold increase is needed in the
transition from bloodstream form to procyclics. Of course a
very strong decrease in ksplicing could reduce the PGKC
mRNA level, but to get 50% of the observed level in blood-
stream forms, ksplicing should be lowered more than 85% (to
0.058 min1) (see Fig. 4).
Although regulation of transcription of specific transcripts is
believed to be absent in trypanosomes because of the polycis-
tronic nature of transcription, transcription may still be substan-
tial when the overall rate of transcription changes between two
different conditions. From the known andmeasured changes in
specific growth rate, mRNA degradation rates andmRNA con-
centrations, degradation was calculated. The sum transcription
precursor processing was then calculated from the summation the-
orem (Equation 15). Table 4 shows the results. The concentra-
tions of PGKB and PGKC mRNA were predominantly regu-
lated by their own degradation (degradation values of 0.85 and
0.84, respectively) and hardly by transcription or splicing.
Because all values were prone to experimental errors, we calcu-
lated the effect of 2-fold changes in each individual degradation
rate constant, and we found that mRNA degradation remained
dominant in all cases. This is especially important in view of the
uncertainty in the half-life of PGKB in procyclics (see above). A
further increase of this half-life to 240min did not substantially
change the results; the degradation would become 1 and the con-
tribution by transcription and splicing would be completely
abolished.
DISCUSSION
In this studywe report a comprehensive analysis of PGKgene
expression in trypanosomes. The interesting issues are how the
synthetic and coding capabilities of the organism are able to
produce sufficient protein molecules, whether there are any
bottlenecks, which processes control the overall process of
mRNA and protein synthesis, and how the organism regulates
expression levels when it undergoes the major switch from its
bloodstream form to its procyclic form. Below we will discuss
first our results in relation to previous results in the literature,
and second their implications for our understanding of
trypanosome gene expression.
Abundance of PGKmRNAandProtein—Thenumber ofPGK
mRNA molecules per cell was quite low, and we wondered
whether this was representative of mRNAmore in general. We
found that there were, on average, 12 PGKC and 72 TUBA
mRNAs per cell. Among the 4632 expressed sequence tags
(ESTs) fromMVAT4 T. brucei rhodesiense bloodstream forms
(61), we found 28 -tubulin ESTs (0.6%) and 3 PGK ESTs
(0.065%). For a total of 20,000 mRNAs per cell, the EST abun-
dances would predict 121TUBA and 13 PGKCmRNAs per cell.
This suggests that representation in the EST data base is a rea-
sonable indication of abundance. The EST frequencies for
other glycolytic enzymes were between 1 and 4, suggesting that
the mRNA abundances are likely to be similar to those of
PGKC. For comparison, yeast cultivated in rich medium was
estimated, by microarray analysis, to contain 60 PGK tran-
scripts per cell. However, 80% of transcripts were present only
at 0.1–2molecules/cell (62). Estimates from solution hybridiza-
tion for various mRNAs yielded estimates of 0.1–77 mole-
cules per yeast cell (63).
TABLE 4
How T. brucei regulates PGKmRNA concentrations when it changes
from its bloodstream form to its procyclic form
The degradation rate constants were calculated from the half-lives reported in the
text, using the formula kdegr
 ln2/t1⁄2; themRNAconcentrationswere as reported in
the text and Table 2. Concentrations are given in molecules/cell;  (specific growth
rate) and kdegr (degradation constant) values are in min1.

PGKBmRNA PGKCmRNA
Concentration kdegr Concentration kdegr
Bloodstream form 0.0019 0.8 0.092 12 0.015
Procyclic form 0.0010 18 0.0058 1.0 0.14
degradation 0.85 0.84
transcriptionsplicing 0.15 0.16
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According to our study a small number of mRNAmolecules
gave rise to approximately one million PGKC protein mole-
cules per cell. The number of protein molecules per mRNA
impressed us. We wondered whether this could be achieved
with realistic translation rates. Our mathematical model
enabled us to calculate the translation rate corresponding to
these measurements. Assuming 12 ribosomes per mRNA, and
12mRNAsper cell, it revealed that a translation rate of about 13
protein molecules per active ribosome per mRNA molecule/
min should be needed (Table 1), andwith a PGKC length of 440
amino acids this corresponds to 97 residues per active ribo-
some/s. The elongation rate for hen ovalbumin was estimated
at 5 residues/s (64); in yeast at 30 °C with glucose, the average
rate was 9 residues/s (65). Considering this, our calculation of
the translation rate of PGK protein is rather high. Our riboso-
mal density estimate of up to 11–14 per mRNA seems reason-
able; in a previous analysis of ribosome occupancy in yeast, the
average number of ribosomes for a 2-kb mRNA was 10, and no
RNA had more than 15 ribosomes, irrespective of length (66).
Cumulative errors in mRNA or protein estimates could pro-
vide an explanation for the high translation rate that we found.
In multiple experiments we never found more than 20 PGKC
mRNAs per trypanosome. Regarding protein, Misset et al. (67)
determined that PGKC represented 0.16% of the total cellular
protein in bloodstream form trypanosomes purified from rats.
If 1 mg corresponds to 1.94  108 cells (17), this leads to an
estimate of 1  105 molecules per cell, which should give a
catalytic activity of 640 nmol min1 mg cell protein1 (10). In
the in vitro cultured trypanosomes that we use, PGK activity
was 4.5-fold higher than this (11), whereas the protein estimate
was 10-fold higher. Thus, our protein measurement is unlikely
to bemore than 2-fold too high. If, however, we assume 5 105
proteins per parasite, and 20 mRNAs, we arrive at a translation
rate of 25 residues/s, which is only twice the yeast value.
Because ribosomes could well elongate faster at 37 °C than at
30 °C, this does not seem unreasonable. The actual rate of
translation does not influence the control analysis described in
this paper, but it will result in a change in the steady-state con-
centration of PGKB and PGKC protein in the model predic-
tions (Table 2).
The Rate of Transcription—We did not measure transcrip-
tion rate directly in nuclear run-on experiments, because these
are done on isolated nuclei and do not measure the in vivo rate.
However, aided by themodelwe could calculate the rate of PGK
transcription from our data (0.24 molecules per cell per min).
Table 5 shows the results of a more detailed analysis, as further
described in the Supplemental Material. The inter-polymerase
spacings for both RNA polymerase I and RNA polymerase II
genes that we calculated were based on the number of mRNAs
that have to made in a certain amount of time, and they were
consistent with values previously reported for other eukaryotes
(63, 69–72). Given the rate of RNA polymerases and the num-
ber of genes to be transcribed, the required average RNA poly-
merase II spacing of around 50 kb on protein-coding genes
means that at any given time, as in other eukaryotes (73, 74),
many open reading frames are not being transcribed. As
expected, the RNA polymerase I density for variant surface gly-
coprotein and rRNA loci was predicted to be much higher than
1/50 kb. ForPGKC andTUBA, the average polymerase spacings
were predicted to be 14 and 30 kb, respectively, in bloodstream
forms.
The Kinetics of Splicing—When we treated trypanosomes
with actinomycin D, the precursor mRNA was spliced with a
half-life of about 1 min. This result is similar to earlier observa-
TABLE 5
Statistics for bloodstream form trypanosome gene expression
Line Model rRNA VSG TotalmRNA SLRNA PGKC -Tubulin
1 Mature transcript length (nucleotides) 6100 2710 2200 35 2140 1545
2 Transcript length (nucleotides) 8550a 2710b 2800c 140c 2340c 1745c
3 No. of genes/haploid genomec 4d 0.5 7400 75d 1 19f
4 No. of genes/average cellg 11.2 1.4 25,390 210 2.8 53
5 No. of molecules per cellh 125,000 1000i 20,000 20,000 12 72
6 Half-life 12 hj 45 minj 30 minj 30 minj 45 mink 30 minl
7 Transcript elongation rate nt/sm 40 40 20 20 20 20
8 Time to make one RNA (min) 3.6 1.2 2.25 0.12 2.0 1.4
9 Molecules cell1 h1 100% processing efficiencyn 21,470 1038 3.0 104 3.0 104 12.5 108
10 RNAs per h per gene 100% processing efficiencyn 1917 742 1.2 143 4.4 2.0
11 Distance between polymerases 100% processing efficiencyn 75 bp 194 bp 61 kb 504 bp 16 kb 35 kb
12 Distance between polymerases 85% processing efficiency 64 bp 165 bp 52 kb 428 bp 14 kb 30 kb
a Primary transcript was deduced from genome sequence (83).
b Shown is VSG117mRNA.
c Data are from genome or EMBL database, and see “Experimental Procedures” and Supplemental Material.
d There are six annotated small subunit rRNA genes (83), but only four promoters as judged by Blast searching and four loci as judged by chromosome blotting (84).
e 100 gene copies per diploid genome by Southern blotting (85) and at least 60 by genome annotation (83).
f Data are from fiber-FISH hybridization (86).
g Data were calculated assuming 55% G1, 30% S-phase, and 15% G2/M (87) and on G2 starting after 3.6 h (88).
hMeasured values are from this paper, except for VSG.
i Data assume that 5% of mRNAs encoded VSG.
j From transcription inhibition experiments and the literature, see SupplementalMaterial for details. The value for totalmRNA is based onhalf-lives varying from12min for actin
to about 60 min for histone H4 (see Ref. 35 and A. Schwede, ZMBH, unpublished results).
k See Ref. 33.
l Data are from transcription inhibition experiments, see text.
m Assumed value was inserted into the calculations. The rate of yeast polymerase I has been estimated at 60 nt/s (69); results for mammalian cells are up to 95 nt/s (89, 90). The
elongation rate for polymerase II is derived frommeasurements in yeast (91); for mammalian cells the average is about 30 nt/s, although if pausing is eliminated the rate is 70
bases/s (68).
n Data were calculated on a population basis, assuming continuous transcription and mRNA degradation and a constant ploidy of 2.8. 100% splicing efficiency, with a doubling
of the RNA quantity once every cell cycle of 6 h, was also assumed. Values for 85% processing efficiency are in line 12.
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tions of permeabilized procyclic trypanosomes, showing trans
splicing of -tubulin, -tubulin, and actin pre-mRNAs within
1–2 min of synthesis of the 3 splice site (75). Because actino-
mycin D also inhibits SLRNA synthesis, it could potentially
interfere with splicing. However, this is probably not significant
in our experiments because (in procyclic forms) the SLRNA has
a half-life of 8 min (76). If the measured half-time for splicing is
typical, RNAs will be spliced when polymerase II has pro-
gressed 1200 nt downstream, based on a polymerase II rate of
20 nucleotides/s (Table 5). YeastmRNAs also are splicedwithin
1 min of formation of the 3 splice site (77–79), and selected
mammalian introns had half-lives ranging from 0.4 to 7.5 min
(80). The similarity of trypanosome trans splicing kinetics with
those for cis splicing in other organisms is quite surprising given
that trans splicing is a two-substrate reaction. Therefore, first-
order decay of the precursor pool suggests that in T. brucei, the
steady-state SLRNA pool is high enough to remain saturating
throughout the experiment. Interestingly, this may not be true
for all kinetoplastids; the steady-state level of SLRNA varies
over a 4-fold range in different Leishmania species, and an
increase in the number of SLRNA genes in Leishmania major
resulted in an increase in virulence (81).
Transcription and Trans Splicing Does Not Regulate Mature
PGK mRNA Levels—A central question of this study was how
mRNA concentrations were regulated in trypanosomes. It was
known already that changes in themRNAdegradation pathway
can have amajor effect onmRNA levels. For instance, depletion
of the exonuclease XRNA increased the stability of PGKB
mRNA in bloodstream forms, with a concomitant increase in
mRNA abundance. It also increased the PGKCmRNA half-life
and level in procyclics, consistent with a major control by
mRNA degradation (35). However, these results do not neces-
sarily imply that the cell uses degradation to regulate mRNA
levels. This study now quantitatively shows that the cells do use
messenger degradation for regulation and that regulation of
other processes makes a very minor contribution, and we will
summarize and discuss the basis for this conclusion.
In metabolic control analysis concentration control coeffi-
cients always sum up to zero (5). In the particular example
studied here, this implied that the negative control exerted by
mRNA degradation onmRNA concentrations was balanced by
a positive control exerted at the mRNA production side. This
could then have been splicing or transcription. Our model cal-
culations showed that in reality the lions share of the positive
control was in transcription, with very little positive control in
splicing. This means that there is a potential to regulate mRNA
levels via transcription; if the transcription rate were to change,
this should strongly affect the concentrations of the mature
mRNA.
The derivation of the regulation coefficients showed that
even in trypanosomes transcription could contribute to the reg-
ulation of mRNA concentrations, for example if the overall
transcription rate were to differ between procyclic and blood-
stream forms (see Equations 15 and 16). This somewhat coun-
terintuitive result is because of the fact that we considered the
absolute concentrations of mRNAs rather than their concen-
trations relative to each other.Whenwe considered the control
of the ratio of the twomRNAs (see Table 3), we found that that
this ratio was not controlled by transcription but was virtually
only controlled by the specific degradation processes of the two
mRNAs. Indeed it follows from Equation 12 that all mRNAs that
are derived from the same precursor are equally sensitive to
changes in the transcription rate, implying that the transcription
rate cannot regulate their relative concentrations.
The fact that transcription strongly controlled the PGK
mRNA concentrations in exponentially growing bloodstream
form trypanosomes could suggest that the organism also used
this to regulate its mRNA concentrations when it transforms to
the procyclic form.We found that this is not the case at all; the
regulation coefficients of absolute concentrations of PGKB and
PGKC mRNA by transcription and precursor processing
together were close to zero, demonstrating that the absolute
mRNA concentrations were hardly regulated by these pro-
cesses. These results illustrate the difference between control
and regulation coefficients; even though the control exerted by
transcription was high, it did not regulate the mRNA levels.
The second striking result that we obtained was that the reg-
ulation by splicing was negligible. Previously, two groups have
investigated trypanosome splicing efficiency by measuring the
expression of luciferase protein from reporter genes with dif-
ferent 5-untranslated regions (5-UTRs) and splicing signals.
There were several differences in reporter protein expression
depending on the sequences used, but the groups came to dia-
metrically opposite conclusions (37, 38). One group, which
changed the splicing signal but not the 5-UTR, concluded that
the PGKC signal functioned poorly in procyclic trypanosomes
(38). The other group used splicing signals with the 5-UTR and
found no difference between the PGKB and PGKC signals (37).
Herewe used a different type of analysis.We did not just ask the
question whether sequence differences could give rise to differ-
ent splicing efficiencies, but to what extent changes of the splic-
ing rate constant could have affected (control) and were varied
to affect (regulation) the mature mRNA concentrations during
differentiation.
The regulation coefficients that we obtained were consistent
with a predominant regulation by mRNA degradation, without
any substantial contribution by precursor processing. Even
though the experimental data, from which the regulation coef-
ficients were calculated, were highly error-prone, we checked
that a 2-fold uncertainty in the mRNA half-lives changed the
regulation coefficients only marginally.
The most convincing argument, however, against a role for
trans splicing in the regulation of mature PGKmRNA concen-
tration is that the potential to regulate is limited. This is seen
from the control coefficients as well as from the response to
larger changes in splicing rate constant. The control coeffi-
cients by splicing were very small (0.17 only), requiring phe-
nomenal changes in splicing activity for a strong change in
mRNA abundance to result.Moreover, thematuremRNA con-
centrations depended hyperbolically on the splicing rate con-
stant (Equation 13). In the bloodstream trypanosomes, the
splicing rate constantwas close to saturating, and no increase in
the splicing activity could increase the level ofmaturemRNAby
more than 25% (Fig. 4). The basis for this is that transcription is
an irreversible process. and whether spliced rapidly or not, the
precursor will end up as mature mRNA. The only processes
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detracting from this are as follows: (i) growth, i.e. if growthwere
rapid enough then splicing rates might not be fast enough to
supply daughter cells with sufficient mature mRNA, or (ii) pre-
cursor degradation. However, precursor degradation was five
times slower than splicing and could therefore not have much
effect, and growth was even 2 orders of magnitude slower than
splicing. Even though the precise rate constants are difficult to
determine, the difference between splicing and precursor deg-
radation kinetics was quite convincing (Fig. 2), which corrobo-
rates our conclusion that the splicing rate constant hardly con-
trolled thematuremRNA concentrations in this case. A further
decrease of the splicing rate constant, however, would start to
affect thematuremRNAconcentrations, demonstrating that in
the case of the PGK genes splicing was only just fast enough
compared with precursor degradation to lose control (Fig. 4).
The interplay between splicing and precursor degradation also
becomes apparent in the fact that their (small) concentration
control coefficients were virtually equal but of opposite sign
(Table 3), demonstrating that the potential to regulate mRNA
concentrations via precursor degradation is as high as via
splicing.
In the above analysis it is assumed that splicing and precursor
degradation compete. however, it could be that precursors are
only degraded if splicing is inhibited, in which case precursor
degradation would be irrelevant in healthy exponentially grow-
ing cells. In the latter case the rate constant for precursor deg-
radation becomes zero, and changes in the splicing rate con-
stant do not affect mRNA pools at all (Equation 13). When the
5-3-exonuclease XRNA (which is in both nucleus and cyto-
plasm) was depleted in bloodstream trypanosomes, the results
obtained were consistent with a role for XRNA in precursor
degradation, and with competition between precursor degra-
dation and splicing (35).
We emphasize that the control analysis was only carried out
in the bloodstream form. It is conceivable that the distribution
of control shifts during differentiation to the insect form. Fur-
thermore, our study was limited to the PGK genes, and it
remains to be seen how other mRNAs are controlled and regu-
lated. However, the conclusion that splicing can only regulate
mRNA concentrations if it is slow compared with precursor
degradation is general and holds for all mRNAs. Finally, this
study yields a theoretical framework, which can be used to dis-
sect regulation of other genes and in other organisms, including
organisms in which transcription is regulated.
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